Clorox (NYSE:CLX – Get Free Report) had its price target lowered by research analysts at Wells Fargo & Company from $140.00 to $135.00 in a research report issued to clients and investors on Thursday, FlyOnTheWall reports. Wells Fargo & Company‘s target price would indicate a potential upside of 8.01% from the company’s previous close.
Several other equities research analysts also recently weighed in on CLX. HSBC began coverage on Clorox in a report on Friday, September 22nd. They set a “hold” rating and a $146.00 price objective on the stock. Bank of America cut their price objective on Clorox from $145.00 to $120.00 and set an “underperform” rating on the stock in a report on Thursday. Atlantic Securities raised Clorox from an “underweight” rating to a “neutral” rating in a report on Thursday, August 3rd. Barclays lifted their target price on Clorox from $117.00 to $127.00 and gave the stock an “underweight” rating in a report on Friday, August 4th. Finally, StockNews.com downgraded Clorox from a “buy” rating to a “hold” rating in a report on Tuesday, September 19th. Seven investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and one has given a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $142.67.
Read Our Latest Research Report on Clorox
Clorox Trading Up 0.0 %
Clorox (NYSE:CLX – Get Free Report) last issued its quarterly earnings results on Wednesday, August 2nd. The company reported $1.67 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.19 by $0.48. Clorox had a return on equity of 163.56% and a net margin of 2.02%. The company had revenue of $2.02 billion for the quarter, compared to analyst estimates of $1.88 billion. During the same quarter last year, the company posted $0.93 EPS. The company’s revenue for the quarter was up 12.1% compared to the same quarter last year. Equities analysts anticipate that Clorox will post 5.86 EPS for the current fiscal year.
Insider Activity at Clorox
In other Clorox news, CFO Kevin B. Jacobsen sold 3,346 shares of the business’s stock in a transaction that occurred on Monday, August 14th. The stock was sold at an average price of $160.82, for a total transaction of $538,103.72. Following the completion of the sale, the chief financial officer now directly owns 23,224 shares of the company’s stock, valued at approximately $3,734,883.68. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.41% of the stock is currently owned by corporate insiders.
Institutional Trading of Clorox
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in CLX. Tyler Stone Wealth Management bought a new stake in Clorox during the 2nd quarter worth approximately $25,000. Dark Forest Capital Management LP purchased a new position in shares of Clorox in the 4th quarter worth approximately $28,000. OLD Mission Capital LLC purchased a new position in shares of Clorox in the 4th quarter worth approximately $29,000. Bogart Wealth LLC boosted its stake in shares of Clorox by 105.6% in the 2nd quarter. Bogart Wealth LLC now owns 185 shares of the company’s stock worth $29,000 after buying an additional 95 shares during the last quarter. Finally, Ten Capital Wealth Advisors LLC boosted its stake in shares of Clorox by 429.7% in the 1st quarter. Ten Capital Wealth Advisors LLC now owns 196 shares of the company’s stock worth $31,000 after buying an additional 159 shares during the last quarter. 77.98% of the stock is owned by institutional investors.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Read More
- Five stocks we like better than Clorox
- What is a Stock Market Index and How Do You Use Them?
- Levi Strauss: A Bottom is in for Steady, Stable Dividend Payer
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Starbucks Is About To Become A Value Play You Can’t Miss
- Investing in Blue-Chip Stocks
- Intel to Unlock Value By Spinning Off Programmable Chip Unit
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.
